Esperion Therapeutics (ESPR) Q2 2024 Earnings

7MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.63
-0.31
0.02
0.34

Details

Expected EPS
0.048692
Actual EPS
0.34
Surprise EPS
0.29
Surprise Percent
+598.27%

Description

Esperion Therapeutics (ESPR) has reported earnings of 0.34 per share for Q2 2024.

0 Comments

Share your thoughts